HAEM5:Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis: Difference between revisions

{{Under Construction}}

}}</blockquote>

Anamaria Munteanu, MD, Ph.D, Harbor-UCLA Medical Center, Fabiola Quintero-Rivera, University of California Irvine

==WHO Classification of Disease==

|}

{| class="wikitable"

|+

|Acceptable

|-

|Not Recommended

|}

|}

No chromosomal rearrangements for MDS/MPN-RS-T

* Chromosomal Rearrangements (Gene Fusions)

* Individual Region Genomic Gain/Loss/LOH

* Gene Mutations (SNV/INDEL)}}</blockquote>

Treatment: transfusions, recombinant human erythropoietin for anemia. The use of Lenalidomide is controversial, while,  the use of Luspatercept- a novel erythroid maturation agent is not an established treatment option. Aspirin for thrombocytosis. Hydroxyurea is the preferred  cytoreductive agent <ref name=":2" />

{| class="wikitable sortable"

|-

|-

|<span class="blue-text">EXAMPLE:</span>

|}

No genomic gain/loss for MDS/MPN-RS-T

!Chromosomal Pattern

!Molecular Pathogenesis

|-

|<span class="blue-text">EXAMPLE:</span>

|}

No recurrent chromosomal aberrations for MDS/MPN-RS-T. However, abnormalities have been reported in 10% of patients. Trisomy 8 and loss of Y are the most common changes.<ref name=":3" />  

{| class="wikitable sortable"

|-

|-

|<span class="blue-text">EXAMPLE:</span>''EGFR''

|}Note: A more extensive list of mutations can be found in [https://www.cbioportal.org/ <u>cBioportal</u>], [https://cancer.sanger.ac.uk/cosmic <u>COSMIC</u>], and/or other databases. When applicable, gene-specific pages within the CCGA site directly link to pertinent external content.

The presence of concomitant  mutations in SF3B1 and JAK2 V617F support the diagnosis of MDS/MPN-RS-T; less commonly encountered are SF3B1 and CALR or SF3B1 and MPL <ref>{{Cite journal|last=S|first=Jeromin|last2=T|first2=Haferlach|last3=S|first3=Weissmann|last4=M|first4=Meggendorfer|last5=C|first5=Eder|last6=N|first6=Nadarajah|last7=T|first7=Alpermann|last8=A|first8=Kohlmann|last9=W|first9=Kern|date=2015|title=Refractory anemia with ring sideroblasts and marked thrombocytosis cases harbor mutations in SF3B1 or other spliceosome genes accompanied by JAK2V617F and ASXL1 mutations|url=https://pubmed.ncbi.nlm.nih.gov/25527566/|language=en|doi=10.3324/haematol.2014.119032|pmc=PMC4380732|pmid=25527566}}</ref><ref name=":3">{{Cite journal|last=L|first=Palomo|last2=M|first2=Meggendorfer|last3=S|first3=Hutter|last4=S|first4=Twardziok|last5=V|first5=Adema|last6=I|first6=Fuhrmann|last7=F|first7=Fuster-Tormo|last8=B|first8=Xicoy|last9=L|first9=Zamora|date=2020|title=Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms|url=https://pubmed.ncbi.nlm.nih.gov/32573691/|language=en|pmid=32573691}}</ref>.

|}

SF3B1 gene mutations are present in over 80% of patients <ref name=":2" />. Somatic mutation in SF3B1 leads to abnormal ABCB7 protein, accumulation of mitochondrial iron and ineffective erythropoiesis, with formation of ring sideroblasts<ref>{{Cite journal|last=M|first=Cazzola|last2=M|first2=Rossi|last3=L|first3=Malcovati|date=2013|title=Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms|url=https://pubmed.ncbi.nlm.nih.gov/23160465/|language=en|doi=10.1182/blood-2012-09-399725|pmc=PMC3790951|pmid=23160465}}</ref>. Mutations in JAK2 correlate with increased platelet count.<ref name=":3" />  

(use the "Cite" icon at the top of the page) <span style="color:#0070C0">(''Instructions: Add each reference into the text above by clicking where you want to insert the reference, selecting the “Cite” icon at the top of the wiki page, and using the “Automatic” tab option to search by PMID to select the reference to insert. If a PMID is not available, such as for a book, please use the “Cite” icon, select “Manual” and then “Basic Form”, and include the entire reference. To insert the same reference again later in the page, select the “Cite” icon and “Re-use” to find the reference; DO NOT insert the same reference twice using the “Automatic” tab as it will be treated as two separate references. The reference list in this section will be automatically generated and sorted''</span><span style="color:#0070C0">''.''</span><span style="color:#0070C0">)</span> <references />

==Notes==

          

<nowiki>*</nowiki>''Citation of this Page'': “Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis”. Compendium of Cancer Genome Aberrations (CCGA), Cancer Genomics Consortium (CGC), updated {{REVISIONMONTH}}/{{REVISIONDAY}}/{{REVISIONYEAR}}, <nowiki>https://ccga.io/index.php/HAEM5:Myelodysplastic/myeloproliferative_neoplasm_with_SF3B1_mutation_and_thrombocytosis</nowiki>.